The Toxoplasmosis Center
The University of Chicago Medicine has developed a unique center to help babies, children, and adults affected by toxoplasmosis. It is one of the only centers in the world that offers comprehensive, lifelong care to people of all ages coping with the adverse effects of congenital toxoplasmosis and other Toxoplasma gondii infections. We have been working with some of the same patients for more than 25 years. For patients with toxoplasmosis, we offer the latest treatment options to improve their quality of life.
Our mission is to:
- Provide the most expert care for people at all stages of life who are infected with Toxoplasma gondii, the parasite that causes the disease toxoplasmosis
- Advance research efforts in preventing and treating infection from the parasite that causes toxoplasmosis, Toxoplasma gondii
Our Clinical Care
At the University of Chicago Medicine, a multidisciplinary team cares for patients with toxoplasmosis, adults with acute acquired infection, immunologically suppressed patients, patients with eye disease, pregnant women and their fetuses affected by toxoplasmosis and infants and children with congenital toxoplasmosis. The team that cares for congenitally infected children includes an infectious disease specialist, a pediatric neurologist, a pediatric ophthalmologist, an occupational therapist, a physical therapist, and many other professionals. Working with a woman’s obstetrician, we can help guide diagnosis and treatment options for the patient and her baby. Expert ophthalmologic care is available for infants, children, and adults with toxoplasmosis involving the eye.
Directed by an internationally recognized and award-winning infectious disease specialist, our center is dedicated to finding ways to prevent and treat this disease. Over the years, we have led national, multicenter studies to understand how T. gondii causes disease. And through research sponsored by the National Institutes of Health, we are leading a multi-center team that is studying new approaches to treating acute and chronic toxoplasmosis infection. For example, we have published research articles on how early treatment with two anti-parasitic drugs can reduce brain and eye damage in babies born with toxoplasmosis. Additional research into vaccines, new medicines, genetics of susceptibility and resistance and other basic aspects of this infection and the parasite that causes it is under way.